SLAMF7 contains one Ig-like C2-type (immunoglobulin-like) domain. Isoform 1 mediates NK cell activation through a SAP-independent extracellular signal-regulated ERK-mediated pathway. It may play a role in lymphocyte adhesion. Isoform 3 does not mediate any activation. SAP can bind the cytoplasmic tail of isoform 1 when phosphorylated in the presence of Fyn (in vitro). SLAMF7 is expressed in spleen, lymph node, peripheral blood leukocytes, bone marrow, small intestine, stomach, appendix, lung and trachea. Expression was detected in NK cells, activated B-cells, NK-cell line but not in promyelocytic, B-, or T-cell lines. The isoform 3 is expressed at much lower level than isoform 1. There are three named isoforms.
InvitrogenCD319 (CRACC) Monoclonal Antibody (162), PE, eBioscience™ CD319 (CRACC) Monoclonal Antibody (162), PE, eBioscience™
Cat # 12-2229-42
InvitrogenCD319 (CRACC) Monoclonal Antibody (162), PerCP-eFluor 710, eBioscience™ CD319 (CRACC) Monoclonal Antibody (162), PerCP-eFluor 710, eBioscience™
Cat # 46-2229-42
If an Invitrogen™ antibody doesn’t perform as described on our website or datasheet, we’ll replace the product at no cost to you, or provide you with a credit for a future purchase.*
Get expert recommendations for common problems or connect directly with an on staff expert for technical assistance related to applications, equipment and general product use.